Articles

16.12.2014 |

GMO authorisation in the EU: The Commission once again attacked for undue delays

Inf’OGM
Inf’OGM

On 17 October 2014, EuropaBio, Fefac and Coceral filed a complaint to the European Ombudsman, Emily O’Reilly, regarding the delay in the authorisation procedures concerning twenty applications for GMOs. This complaint occurs while the European bodies are close to an agreement on the GMO opt-out proposal, an agreement supposedly aimed at “unblocking” the GMO authorisation process.

The Ombudsman’s website does mention the case but does not provide detailed information. The small amount of information that is provided states that the complaint concerns allegations of maladministration by the European Commission of the GMO applications. The European Commission is accused of having breached its duties relating to a “reasonable time-limit for taking decisions”. The Ombudsman’s office told Inf’OGM that the plaintiffs are EuropaBio (European Association for Bioindustries), the European Feed Manufacturers’ Federation (FEFAC) and the European association representing the trade in cereals, rice, feedstuffs, oilseeds, olive oil, oils and fats and agrosupply (Coceral).

The three associations consider that the European Commission has badly administered twenty applications of GMOs for import, food and feed under regulation 1829/2003 by causing “illegal and unreasonable delays”. They claim that the “Commission should put to vote in the relevant committee and/or adopt a formal decision on the twenty pending applications and abstain from causing any such delays in the authorisation process in the future”.

The Ombudsman’s office told Inf’OGM that they had only published limited information so far as the case is ongoing. They added that they have already “inspected the relevant files in the Commission” and that they are “waiting for the Commission’s opinion on the allegations which they should submit by the end of January 2015”. At the time of publication of this article, Inf’OGM was still expecting requested comments from Fefac, Coceral and EuropaBio.

Zurück zu den Meldungen

EnglishFranceDeutsch